| Zoetis (ZTS) |
United States |
$74.564B |
42.41 |
| Takeda Pharmaceutical (TAK) |
Japan |
$58.294B |
10.16 |
| Astellas Pharma (ALPMY) |
Japan |
$29.965B |
15.18 |
| Eisai (ESALY) |
Japan |
$27.403B |
23.16 |
| UCB SA (UCBJF) |
Belgium |
$23.720B |
0.00 |
| Merck (MKGAF) |
Germany |
$17.131B |
22.47 |
| Catalent (CTLT) |
United States |
$13.151B |
50.84 |
| Grifols, S.A (GRFS) |
Spain |
$12.369B |
15.12 |
| Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) |
Italy |
$11.140B |
0.00 |
| Neurocrine Biosciences (NBIX) |
United States |
$10.539B |
40.80 |
| Ono Pharmaceutical (OPHLF) |
Japan |
$9.254B |
16.36 |
| Ionis Pharmaceuticals (IONS) |
United States |
$7.463B |
47.27 |
| Orion OYJ (ORINY) |
Finland |
$7.077B |
24.56 |
| Hikma Pharmaceuticals Plc (HKMPF) |
United Kingdom |
$7.052B |
0.00 |
| STADA ARZNEIMI (STDAF) |
Germany |
$6.858B |
0.00 |
| Jazz Pharmaceuticals (JAZZ) |
Ireland |
$6.803B |
11.25 |
| United Therapeutics (UTHR) |
United States |
$4.848B |
11.21 |
| Arrowhead Pharmaceuticals (ARWR) |
United States |
$4.151B |
0.00 |
| Evotec AG (EVTCY) |
Germany |
$4.113B |
110.84 |
| FibroGen (FGEN) |
United States |
$4.069B |
0.00 |
| Hypermarcas (HYPMY) |
Brazil |
$3.887B |
14.30 |
| ChemoCentryx (CCXI) |
United States |
$3.697B |
0.00 |
| Nektar Therapeutics (NKTR) |
United States |
$3.650B |
0.00 |
| PTC Therapeutics (PTCT) |
United States |
$3.250B |
0.00 |
| Sage Therapeutics (SAGE) |
United States |
$2.670B |
0.00 |
| Pacira BioSciences (PCRX) |
United States |
$2.563B |
67.37 |
| Taro Pharmaceutical Industries (TARO) |
Israel |
$2.442B |
11.82 |
| Cronos Group (CRON) |
Canada |
$1.942B |
0.00 |
| Revolution Medicines (RVMD) |
United States |
$1.848B |
0.00 |
| Xencor (XNCR) |
United States |
$1.832B |
0.00 |
| Aurinia Pharmaceuticals Inc (AUPH) |
Canada |
$1.765B |
0.00 |
| USANA Health Sciences (USNA) |
United States |
$1.741B |
16.40 |
| Indivior (INVVY) |
United States |
$1.614B |
20.00 |
| Ironwood Pharmaceuticals (IRWD) |
United States |
$1.583B |
11.03 |
| Corcept Therapeutics (CORT) |
United States |
$1.561B |
14.37 |
| Akebia Therapeutics (AKBA) |
United States |
$1.473B |
0.00 |
| Heron Therapeutics (HRTX) |
United States |
$1.413B |
0.00 |
| Zogenix (ZGNX) |
United States |
$1.372B |
0.00 |
| AMNEAL PHARMACEUTICALS, INC (AMRX) |
United States |
$1.264B |
12.06 |
| VAXART, INC (VXRT) |
United States |
$1.174B |
0.00 |
| CLINIGEN GP (CLIGF) |
United Kingdom |
$1.102B |
0.00 |
| Theravance Biopharma (TBPH) |
Cayman Islands |
$1.090B |
0.00 |
| Karyopharm Therapeutics (KPTI) |
United States |
$1.078B |
0.00 |
| Translate Bio (TBIO) |
United States |
$1.056B |
0.00 |
| Enanta Pharmaceuticals (ENTA) |
United States |
$0.951B |
592.13 |
| Esperion Therapeutics (ESPR) |
United States |
$0.932B |
0.00 |
| Tilray (TLRY) |
Canada |
$0.865B |
0.00 |
| Altimmune (ALT) |
United States |
$0.739B |
0.00 |
| Vectura Group (VEGPF) |
United Kingdom |
$0.737B |
0.00 |
| Endo (ENDP) |
Ireland |
$0.729B |
1.08 |
| Trillium Therapeutics (TRIL) |
Canada |
$0.705B |
0.00 |
| BioCryst Pharmaceuticals (BCRX) |
United States |
$0.699B |
0.00 |
| ImmunoGen (IMGN) |
United States |
$0.672B |
0.00 |
| Collegium Pharmaceutical (COLL) |
United States |
$0.653B |
0.00 |
| Molecular Templates (MTEM) |
United States |
$0.599B |
0.00 |
| Flexion Therapeutics (FLXN) |
United States |
$0.597B |
0.00 |
| Radius Health (RDUS) |
United States |
$0.574B |
0.00 |
| Aerie Pharmaceuticals (AERI) |
United States |
$0.572B |
0.00 |
| Corbus Pharmaceuticals Holdings (CRBP) |
United States |
$0.569B |
0.00 |
| Siga Technologies (SIGA) |
United States |
$0.554B |
59.08 |
| Crinetics Pharmaceuticals (CRNX) |
United States |
$0.516B |
0.00 |
| Ocular Therapeutix (OCUL) |
United States |
$0.510B |
0.00 |
| Innate Pharma SA (IPHYF) |
France |
$0.506B |
0.00 |
| Ardelyx (ARDX) |
United States |
$0.497B |
0.00 |
| BioSpecifics Technologies Corp (BSTC) |
United States |
$0.468B |
23.36 |
| DURECT (DRRX) |
United States |
$0.461B |
0.00 |
| Rigel Pharmaceuticals (RIGL) |
United States |
$0.429B |
0.00 |
| Spectrum Pharmaceuticals (SPPI) |
United States |
$0.429B |
0.00 |
| Organogenesis Holdings (ORGO) |
United States |
$0.427B |
0.00 |
| TherapeuticsMD (TXMD) |
United States |
$0.422B |
0.00 |
| Catalyst Pharmaceuticals (CPRX) |
United States |
$0.346B |
8.56 |
| Harpoon Therapeutics (HARP) |
United States |
$0.344B |
0.00 |
| IMV INC (IMV) |
Canada |
$0.335B |
0.00 |
| Redhill Biopharma (RDHL) |
Israel |
$0.316B |
0.00 |
| Heat Biologics (HTBX) |
United States |
$0.316B |
0.00 |
| Concert Pharmaceuticals (CNCE) |
United States |
$0.299B |
0.00 |
| OptiNose (OPTN) |
United States |
$0.298B |
0.00 |
| MEI Pharma (MEIP) |
United States |
$0.296B |
0.00 |
| Calithera Biosciences (CALA) |
United States |
$0.293B |
0.00 |
| Avadel Pharmaceuticals (AVDL) |
Ireland |
$0.290B |
0.00 |
| Rafael Holdings (RFL) |
United States |
$0.285B |
0.00 |
| PROFOUND MEDICL (PROF) |
Canada |
$0.279B |
0.00 |
| Oasmia Pharmaceutical AB (OASMY) |
Sweden |
$0.275B |
0.00 |
| Lannett Co Inc (LCI) |
United States |
$0.249B |
5.45 |
| CASI Pharmaceuticals (CASI) |
United States |
$0.240B |
0.00 |
| Aquestive Therapeutics (AQST) |
United States |
$0.222B |
0.00 |
| Nature's Sunshine Products (NATR) |
United States |
$0.216B |
21.33 |
| KalVista Pharmaceuticals (KALV) |
United States |
$0.204B |
0.00 |
| Taiwan Liposome (TLC) |
Taiwan |
$0.194B |
0.00 |
| Nivalis Therapeutics (ALPN) |
United States |
$0.189B |
0.00 |
| Onconova Therapeutics (ONTX) |
United States |
$0.186B |
0.00 |
| Matinas Biopharma Holdings (MTNB) |
United States |
$0.170B |
0.00 |
| Jounce Therapeutics (JNCE) |
United States |
$0.163B |
7.69 |
| Xeris Pharmaceuticals (XERS) |
United States |
$0.124B |
0.00 |
| Champions Oncology (CSBR) |
United States |
$0.117B |
0.00 |
| Summit Therapeutics (SMMT) |
United Kingdom |
$0.114B |
0.00 |
| AcelRx Pharmaceuticals (ACRX) |
United States |
$0.110B |
0.00 |
| ALLERGY THERAPT (AGYTF) |
United Kingdom |
$0.108B |
0.00 |
| Otonomy (OTIC) |
United States |
$0.103B |
0.00 |
| Aptorum Group (APM) |
Hong Kong, SAR China |
$0.102B |
0.00 |
| Lipocine (LPCN) |
United States |
$0.102B |
0.00 |
| Biomerica (BMRA) |
United States |
$0.101B |
0.00 |
| La Jolla Pharmaceutical (LJPC) |
United States |
$0.098B |
0.00 |
| MediWound (MDWD) |
Israel |
$0.097B |
0.00 |
| Aclaris Therapeutics (ACRS) |
United States |
$0.097B |
0.00 |
| Galmed Pharmaceuticals (GLMD) |
Israel |
$0.094B |
0.00 |
| CTI BioPharma (CTIC) |
United States |
$0.094B |
0.00 |
| Hemispherx BioPharma (AIM) |
United States |
$0.090B |
0.00 |
| MARKER THERAPEUTICS, INC (MRKR) |
United States |
$0.090B |
0.00 |
| Adamis Pharmaceuticals (ADMP) |
United States |
$0.084B |
0.00 |
| Addex Therapeutics (ADXN) |
Switzerland |
$0.079B |
0.00 |
| ElectroCore (ECOR) |
United States |
$0.076B |
0.00 |
| Recro Pharma (REPH) |
United States |
$0.076B |
0.00 |
| SCYNEXIS (SCYX) |
United States |
$0.072B |
0.00 |
| Infinity Pharmaceuticals (INFI) |
United States |
$0.069B |
0.00 |
| CV Sciences (CVSI) |
United States |
$0.067B |
0.00 |
| ASSERTIO THERAPEUTICS, INC (ASRT) |
United States |
$0.065B |
0.00 |
| GTx (ONCT) |
United States |
$0.060B |
0.00 |
| Sundial Growers (SNDL) |
Canada |
$0.058B |
0.00 |
| PolarityTE (PTE) |
United States |
$0.056B |
0.00 |
| RENEURON GP (RNUGF) |
United Kingdom |
$0.053B |
0.00 |
| Cumberland Pharmaceuticals (CPIX) |
United States |
$0.051B |
30.73 |
| Novan (NOVN) |
United States |
$0.049B |
0.00 |
| AgeX Therapeutics (AGE) |
United States |
$0.049B |
0.00 |
| Natural Alternatives (NAII) |
United States |
$0.047B |
0.00 |
| IsoRay (ISR) |
United States |
$0.046B |
0.00 |
| Forward Pharma (FWP) |
Denmark |
$0.044B |
0.00 |
| Jaguar Animal Health (JAGX) |
United States |
$0.043B |
0.00 |
| Entasis Therapeutics Holdings (ETTX) |
United States |
$0.043B |
0.00 |
| Mannatechorporated (MTEX) |
United States |
$0.042B |
9.36 |
| Opiant Pharmaceuticals (OPNT) |
United States |
$0.039B |
0.00 |
| Bellicum Pharmaceuticals (BLCM) |
United States |
$0.036B |
0.00 |
| Neos Therapeutics (NEOS) |
United States |
$0.035B |
0.00 |
| Can-Fite Biopharma (CANF) |
Israel |
$0.033B |
0.00 |
| Dipexium Pharmaceuticals (PLXP) |
United States |
$0.031B |
0.00 |
| ProPhase Labs (PRPH) |
United States |
$0.030B |
0.00 |
| NovaBay Pharmaceuticals (NBY) |
United States |
$0.030B |
0.00 |
| India Globalization Capital (IGC) |
United States |
$0.026B |
0.00 |
| Vical (BBI) |
United States |
$0.022B |
0.00 |
| Iterum Therapeutics (ITRM) |
Ireland |
$0.021B |
0.00 |
| Eyegate Pharmaceuticals (EYEG) |
United States |
$0.019B |
0.00 |
| Bio-Path Holdings (BPTH) |
United States |
$0.018B |
0.00 |
| RXi Pharmaceuticals (PHIO) |
United States |
$0.016B |
0.00 |
| Sonoma Pharmaceuticals (SNOA) |
United States |
$0.016B |
0.00 |
| Flex Pharma (SLRX) |
United States |
$0.015B |
0.00 |
| Regulus Therapeutics (RGLS) |
United States |
$0.015B |
0.00 |
| Cyanotech (CYAN) |
United States |
$0.014B |
21.36 |
| Shineco (TYHT) |
China |
$0.014B |
0.00 |
| China SXT Pharmaceuticals (SXTC) |
China |
$0.013B |
0.00 |
| Midatech Pharma (MTP) |
United Kingdom |
$0.013B |
0.00 |
| Cytori Therapeutics Inc (PSTV) |
United States |
$0.012B |
0.00 |
| HANCOCK JAFFE (HJLI) |
United States |
$0.009B |
0.00 |
| Xenetic Biosciences (XBIO) |
United States |
$0.008B |
0.00 |
| CannTrust Holdings (CTST) |
Canada |
$0.000B |
0.00 |
